Keywords: gilead, adefovir, works, hiv/hbv, co-infection, sciences, antiviral

Gilead's adefovir works in HIV/HBV co-infection

Article | 31 August 2001

Print This

Gilead Sciences' antiviral drug adefovir dipivoxil, which is currentlyin Phase III development for chronic hepatitis B virus infection, is an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in